Area under the plasma concentration versus time curve (AUC) 0 to 168 hours postdose [clinicaltrials_resource:18f1ad0c064196dc58c7b1a97cbf0c98]
TD-1211 IV [C14]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Area under the plasma concentration versus time curve (AUC) 0 to 168 hours postdose [clinicaltrials_resource:18f1ad0c064196dc58c7b1a97cbf0c98]
TD-1211 IV [C14]
Bio2RDF identifier
18f1ad0c064196dc58c7b1a97cbf0c98
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:18f1ad0c064196dc58c7b1a97cbf0c98
measure [clinicaltrials_vocabulary:measure]
Area under the plasma concentration versus time curve (AUC)
time frame [clinicaltrials_vocabulary:time-frame]
0 to 168 hours postdose
description
TD-1211 IV [C14]
identifier
clinicaltrials_resource:18f1ad0c064196dc58c7b1a97cbf0c98
title
Area under the plasma concentration versus time curve (AUC) 0 to 168 hours postdose
@en
type
label
Area under the plasma concentr ...... 1ad0c064196dc58c7b1a97cbf0c98]
@en